Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Walk in the Windy City

David S. Pisetsky, MD, PhD  |  Issue: December 2011  |  December 12, 2011

Biology is complicated, however, and not every protein, RNA, or metabolite that shows up as a blip in an “omics” profile will make a good biomarker or target of therapy. There is much randomness, serendipity, and luck in the journey from bench to bedside. Please remember that anti–tumor necrosis factor started out as a drug for sepsis and that allopurinol was invented as a way to increase blood levels of 6-mercaptopurine to treat malignancy. Furthermore, some of the key insights into gout—a common disease of older people—came from the investigations of rare genetic diseases of children. The study of Lesch-Nyhan syndrome helped elucidate purine metabolism while the study of conditions like Muckle-Wells syndrome demonstrated how inflammasome triggering can lead to interleukin (IL)-1 production. Fortunately, for children with autoinflammatory diseases, anikinra (IL-Ra) is available as a treatment; although IL1-Ra was conceived initially as a sepsis drug, it got its first approval for rheumatoid arthritis.

My pizza finally arrived, and this bubbling cauldron of molten mozzarella and tomato embedded with chunks of peppery meat was a culinary hit. Whatever it lacked in finesse, it made up in flavor, and the tiramisu for dessert was quite creditable. After my dinner, I walked back to my hotel. The wind had picked up and the air pulsed with the stroboscope lights of evening traffic and the whoosh and whine of speeding cars. Every so often, in the distance, I could hear a Bears’ fan bellowing still another exultant whoop over the victory on the gridiron. The mood of the city seemed upbeat.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A Somber Note on the Magnificent Mile

On New York’s Fifth Avenue, St. Patrick’s Cathedral stands as a majestic Gothic monument that looks as if it were plucked from Chartres or Beauvais and resettled in Gotham. The Magnificent Mile has no such formidable edifice, but there is jewel of a church—a miniature Gothic—called the Fourth Presbyterian Church right across from the John Hancock Center. I never knew that Presbyterian churches were called something other than the first. Here in Chicago was the fourth. Where are the second and third?

In front of the church there was a small grassy area enclosed by a black wrought-iron fence and shaded by a gracious oak tree, leaves still in place despite swirling winds of autumn. My eyes were immediately drawn to a display in this area. Suspended on grooved and rusted iron rods six or seven feet high, the kind used in construction to reinforce concrete, were tens of tee shirts—pink, grey, red, some striped, many with lettering or logos. At first I thought the tee shirts looked like flags or flowers in bloom, a celebration of some kind, but my impression changed quickly when I read the sign that accompanied the exhibit.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:AC&Rrheumatologist

Related Articles

    Chicago My Way: Anne-Marie Malfait, MD, PhD, Provides Insider Info

    October 7, 2011

    Chicago is a city with remarkable shopping opportunities, upscale and trendy neighborhood boutiques, galleries, and specialty shops. Chicago’s great magic lies in its mix: sophisticated-yet-friendly, bustling city streets adjacent to long stretches of green parks and sparkling blue Lake Michigan.

    Atlanta My Way: ACR/ARHP Annual Scientific Meeting

    October 1, 2010

    Atlanta offers its visitors just about everything—from historic places, museums, and venues to restaurants and nightlife. We’ve asked a few ACR and ARHP staff members to share their favorite restaurants and things to do to help ACR/ARHP Annual Scientific Meeting attendees feel more at home in the ACR’s hometown.

    Birthday in Bean Town

    November 1, 2007

    As TR celebrates one year, we look forward to an exciting 2008

    What to See in Chicago during the 2018 ACR/ARHP Annual Meeting

    September 18, 2018

    With magnificent skylines and a reputation for art, culture and fun, Chicago is a great setting for the 2018 ACR/ARHP Annual Meeting. Here are some must-see places in our host city…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences